Medgenics Announces New Executive Leadership Team
September 16 2013 - 6:30AM
Business Wire
New team includes President and CEO Michael
Cola formerly with Shire and Safeguard Scientifics, CFO John Leaman
formerly with Shire and McKinsey, and Global Head of R&D Garry
Neil formerly with Apple Tree Partners and Johnson &
Johnson
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Aevi Genomic Medicine Inc (NASDAQ): 0 recent articles
More Medgenics, Inc. News Articles